- Letter to the editor: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
-
Kadihasanoglu M, Ozbek E
- KMID: 2359878
- Korean J Urol.
- 2015 Dec;56(12):845-846.
- doi: 10.4111/kju.2015.56.12.845
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Intravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result
-
Irkilata L, Aydin M, Aydin HR, Cihan Demirel H, Kadihasanoglu M, Atilla MK
- KMID: 2380832
- Int Neurourol J.
- 2015 Jun;19(2):85-89.
- doi: 10.5213/inj.2015.19.2.85
PURPOSE: This study aimed to verify the efficacy and safety of intravesical treatment with sodium chondroitin sulfate (CS) in patients with overactive bladder (OAB) who are refractory to previous antimuscarinic... -
- CITED
-
- Close
- SHARE
-
- Close
- Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response
-
Sahin Y, Yucetas U, Ates HA, Erkan E, Yucetas E, Temiz MZ, Toktas MG, Kadihasanoglu M, Topkaya BC
- KMID: 2455961
- Investig Clin Urol.
- 2019 Sep;60(5):343-350.
- doi: 10.4111/icu.2019.60.5.343
PURPOSE: To investigate whether measurement of urinary calprotectin can serve as a biomarker in the diagnosis of primary bladder cancer and to confirm its diagnostic role in determining high grade... -
- CITED
-
- Close
- SHARE
-
- Close
